This compound is a pharmaceutical intermediate featuring a pyrimidinedione ring substituted with chlorine and a fluorobenzonitrile moiety. It is primarily used in the synthesis of active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 865759-24-6
1H-Imidazole-1-ethanamine, 4-amino-N-(2,2-dimethylpropyl)-beta,beta-dimethyl-
Pharmaceutical intermediate
1,1-Dimethylethyl N-((1S,3S)-3-((4-methoxy-3-(3-methoxypropoxy)phenyl)methyl)-4-methyl-1-((2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl)pentyl)carbamate
Aliskiren intermediate
2-(Chloromethyl)-4-methoxy-3-methylpyridine--hydrogen chloride (1/1)
Pharmaceutical intermediate synthesis
2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine Hydrochloride
Pharmaceutical intermediate
2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
pharmaceutical intermediate
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-benzonitrile-d3
pharmaceutical impurity reference standard
2-((6-Chloro-3-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
Alogliptin benzoate impurity intermediate
1-(2-Fluoro-6-(trifluoromethyl)benzyl)-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione
pharmaceutical intermediate
2-[(6-chloro-3-methyl-2,4-dioxopyrimidin-1-yl)methyl]-4-fluorobenzonitrile
DNCGCZRILRRTMK-UHFFFAOYSA-N
CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)Cl
—